Neuroimaging and proteomic tracking of neurodegeneration in MPTP-treated mice

Howard E. Gendelman, Christopher J. Destache, Marina L. Zelivyanskaya, Jay A. Nelson, Michael D. Boska, Toni M. Biskup, Michael K. McCarthy, Kimberly A. Carlson, Craig Nemechek, Eric J. Benner, R. Lee Mosley

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)319-321
Number of pages3
JournalAnnals of the New York Academy of Sciences
Volume991
StatePublished - Jan 1 2003

Keywords

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  • Dopamine
  • Magnetic resonance imaging (MRI)
  • Magnetic resonance spectroscopic imaging (MRSI)
  • Mouse
  • Neurodegeneration
  • Proteomics
  • Single-photon emission computed tomography (SPECT)
  • Tyrosine hydroxylase

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Gendelman, H. E., Destache, C. J., Zelivyanskaya, M. L., Nelson, J. A., Boska, M. D., Biskup, T. M., McCarthy, M. K., Carlson, K. A., Nemechek, C., Benner, E. J., & Mosley, R. L. (2003). Neuroimaging and proteomic tracking of neurodegeneration in MPTP-treated mice. Annals of the New York Academy of Sciences, 991, 319-321.